Position in FRNM
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$8,145,225
-$1,529,550 QoQ
Shares Held
742,500
0.0% QoQ
Ownership
7.20%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in FRNM Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026RTW INVESTMENTS, LP holds $723,822,310 across 7 Diagnostics & Research names. FRNM ranks #6 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NTRA |
Natera, Inc.
|
1,250,000 | $249,987,500 | |
| 2 | RDNT |
RadNet, Inc.
|
4,285,000 | $239,488,650 | |
| 3 | GH |
Guardant Health, Inc.
|
1,481,033 | $136,803,018 | |
| 4 | CSTL |
Castle Biosciences Inc
|
2,758,335 | $67,717,124 | |
| 5 | FLGT |
Fulgent Genetics, Inc.
|
1,289,000 | $20,495,100 | |
| 6 | FRNM |
Freenome, Inc.
This page
|
742,500 | $8,145,225 | |
| 7 | XGN |
Exagen Inc.
|
395,231 | $1,185,693 |
All Filings in FRNM
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,145,225 | 742,500 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $9,674,775 | 742,500 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $7,870,500 | 742,500 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $7,885,350 | 742,500 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $7,647,750 | 742,500 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $7,558,650 | 742,500 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $7,439,850 | 742,500 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $7,469,550 | 742,500 | Shares | Sole | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||